Long-term outcome of patients with antiphospholipid syndrome who undergo percutaneous coronary intervention

Leor Perl1, Adi Netzer, Eldad Rechavia

  • 1Rabin Medical Center, The Sackler Faculty of Medicine, Tel Aviv University, 39 Jabotinsky St., Petah-Tikva 49100, Israel. leorperl@gmail.com

Cardiology
|June 23, 2012
PubMed

Insights

Patients with antiphospholipid antibody syndrome (APS) undergoing percutaneous coronary intervention (PCI) experience higher rates of revascularization and major adverse cardiac events. However, myocardial infarction and mortality rates remain similar compared to other PCI patients.

Area of Science:

  • Cardiology
  • Immunology
  • Vascular Medicine

Background:

  • Antiphospholipid antibody syndrome (APS) is associated with increased atherothrombotic risk.
  • Limited data exist on the outcomes of APS patients undergoing percutaneous coronary intervention (PCI).

Purpose of the Study:

  • To evaluate the long-term clinical outcomes of patients with APS following PCI.
  • To compare APS patients undergoing PCI with matched control groups.

Main Methods:

  • Retrospective comparison of 19 APS patients who underwent PCI (2003-2008) with 380 matched PCI patients and 1,458 ST-elevation myocardial infarction patients treated with PCI.
  • Clinical outcomes assessed over a 6-month to 4-year follow-up period.

Main Results:

  • APS patients undergoing PCI had a higher incidence of acute coronary syndrome as the indication for the procedure.
  • One-year follow-up revealed significantly higher rates of target vessel revascularization in APS patients.
  • This led to increased rates of major adverse cardiac events in the APS group, with no significant differences in MI or mortality.

Conclusions:

  • APS patients undergoing PCI demonstrate poorer long-term clinical outcomes primarily due to increased revascularization needs.
  • Further research is necessary to elucidate the underlying mechanisms driving these adverse outcomes in APS patients post-PCI.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...